Replies to post #2366 on China BioPharma Corp (fka CHBO)

[Ben88]

$975K revenue is a tremendous improvement. This is encouraging and moving in a positive direction! Need to increase revenue growth and also improve gross margins to much more than 3.3%.

Also need to continue to keep dilution under control. O/s going from 160 million to 170 million seems ok for the moment. The concern here is that the A/S is being increased from 200 miilion to 700 million shares! Looks like CBPC management is preparing for a potential big increase in the O/S! The default in payments due is likely to lead to the big increase in issue of shares.


All in all, a very encouraging quarter. Keep it up!!